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Background: Fecal calprotectin (FC) is an established simple biomarker of gut inflammation. To examine a possible
relationship between linear growth and gut inflammation, we compared fecal calprotectin levels in 6 month old
infants from poor rural vs affluent urban families.
Methods: The project was a cross-sectional comparison of FC from rural and urban populations in China. The
relationship between length-for-age Z-score (LAZ) and FC concentrations were also compared. Single fecal samples
were assayed for FC using EK-CAL ELISA kits.
Results: The age of subjects for both locations was 6.1 ± 0.2 mo; all were apparently healthy. The mean ± SD of the
LAZ for the rural and urban infants were −0.6 ± 0.9 and 0.4 ± 0.9, respectively. FC had a non-normal distribution. The
median FC of 420.9 and 140.1 μg/g for rural and urban infants, respectively, were significantly different (P< 0.0001).
For the rural group, linear regression analysis showed that an increase in FC of 100 μg/g was associated with a
decrease of 0.06 in LAZ.
Conclusion: FC levels were significantly elevated in the rural infants and high concentrations accounted for
approximately one-third of the low LAZ scores of these infants.
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The unhygienic and unsanitary environment typical of so
many children in poor communities worldwide has been
incriminated as a factor of note in the early onset of
impaired linear growth in infants in these communities [1].
However, quantitative information remains limited on the
role of unhygienic, unsanitary, poor environments per se
on intestinal inflammation and associated linear growth
failure [2-5]. Lunn and Campbell, et al. [2] proposed that
frequent gastrointestinal infections, arising from unhygienic
and unsanitary environments, impair small intestinal muco-
sal function, and explained up to 64% of the observed
height and weight faltering of Gambian infants. Recently,* Correspondence: Michael.Hambidge@ucdenver.edu
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reproduction in any medium, provided the orworks in Bangladesh and Nepal further confirmed the asso-
ciation of gut damage and growth faltering [6,7].
Calprotectin is a calcium and zinc binding protein in
the S100 family with a total molecular mass of 36.5 kD
[8-10]. It is abundant in neutrophilic granulocytes,
monocytes and macrophages, accounting for 60% of all
cytosolic protein in neutrophils. Neutrophils comprise
part of the intestinal innate immune system and pass
through the intestinal wall resulting in increase in secre-
tion of calprotectin which is excreted in the feces intact.
Fecal calprotectin (FC) is an established biomarker of in-
testinal inflammation [11-14]. Most recently, fecal cal-
protectin levels have also been found to be associated
with persistent Giardia and microscopic duodenal in-
flammation [15]. Only a gram or less of sample is
required with improved assays and the FC is remarkably
resilient to degradation for more than a week at room
temperature [16]. The application of FC assays providesThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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rence and severity of intestinal inflammation between
communities exposed to different environments. We
hypothesized that FC levels in mid-infancy are higher in
a rural population than in a middle income urban popu-
lation, and that FC levels are negatively associated with
the rural infants’ growth.
Methods
Study design
The project was a cross-sectional comparison of fecal
calprotectin concentrations in infants at the age of 6 mo
in two Chinese populations: one poor rural, the other
upper-middle income urban. We also examined the rela-
tionship between length-for-age Z-scores (LAZ) and
fecal calprotectin levels.
Subjects
The subjects were infants aged 6 ± 1 mo. One-hundred-
and-five infants were located in the relatively poor rural
county of Xichou located in southwest China. All were
apparently healthy with no evidence of acute or chronic
disease or congenital malformations. This study resulted
from a hypothesis that developed late in the course of
6-mo baseline data collection for the primary study, and
rural samples were limited to all infants - no refusals or
exclusions and none with recent history of diarrhea -
who had not already had their baseline visit. Hence
sample size was dictated by practical limitations rather
than by power testing. The primary study was a comple-
mentary feeding study commencing after these baseline
studies (Sheng et at, unpublished). The rural subjects
were from 60 rural villages in Xichou county. The sam-
ple size for the urban infants was also dictated by prac-
tical considerations. For a limited time period all infants
seen at Kongjiang Community Health Center, Shanghai,
for a routine health check at age 6 months were invited
to participate with 100% acceptance. These were healthy
term singleton infants from upper-middle class families
delivered between 37–42 wk gestation with birth weights
of 2,500-4000 g. Infants with history of diarrhea or re-
spiratory tract infection within previous 2 weeks were
excluded.
Written informed consent was obtained from the
mother of each infant. The research protocol was
approved by Shanghai Jiao Tong University School of
Medicine Xinhua Hospital Institute Review Board and
the Colorado Multiple Institutional Review Board.
Anthropometric measurements
Infant anthropometric measurements were undertaken
in duplicate by a trained member of the research team.
Lengths were measured following standard techniques
using a portable seca infantometer (seca corp, Hanover,MD, USA, 0.1 cm precision) and seca electronic scale
(5 g precision). If the two length measurements differed
by > 0.4 cm, a third measurement was taken. The mean
of the two closest length measurements were recorded.
Fecal collection, transport and storage
A plastic container was distributed to the mothers who
were instructed on collection of a stool sample and to
take precautions against contamination with soil or dirt.
The stool sample was collected on the same day or a day
before the study visit. Samples were stored at −20°C.
The samples from Yunnan rural infants were transferred
frozen to Shanghai.
Calprotectin assays
The fecal samples were analyzed within three months of
collection. FC levels were measured using an EK-CAL
ELISA kit (Bühlmann Laboratories AG, Switzerland),
following the manufacturer’s instructions. The frozen
samples were defrosted at room temperature. The empty
polypropylene tube together with the inoculation loop
was labeled and weighed. Approximately 50 ~ 100 mg of
the fecal sample were transferred into a pre-weighed
tube by means of an inoculation loop. The net amount
of sample was weighed then broken off the inoculation
loop leaving the lower part of the loop in the tube. Ex-
traction buffer (49 × net weight) was added to the tube
and the tube was closed before sample homogenization
on a multi-tube vortexer with vigorous shaking for
30 min. The homogenate was transferred into a 2 mL
polypropylene tube and centrifuged in a microcentrifuge
for 5 min at 3000 × g. The supernatant was transferred
into a fresh, labeled tube for the ELISA procedure. The
lower range procedure (working range 10 ~ 600 μg/g)
was chosen to perform the ELISA assay in the first two
batches which included 98 samples. The fecal extracts
were diluted 1:50 with incubation buffer and the absorb-
ance was read at 450 nm in a microtiter plate reader.
Unexpectedly, 29 samples, all but one from the rural
infants, read higher than the top calibration. Because no
sample material was available for further analysis,
these samples could only be quantified as having FC
levels > 600 μg/g. Subsequently, the remaining extract
was stored and if analytical results exceeded the top cali-
brator, second fecal extracts were further diluted 1:6
with incubation buffer and assayed again.
Statistical analyses
(LAZ), weight-for-age (WAZ), and weight-for-length
(WLZ) Z-scores were calculated with Anthro (version
3.1) using World Health Organization Child Growth
standards. Comparison tests of LAZ, WAZ and WLZ
were performed using t-tests. Because FC data were
found to have a non-normal distribution, comparison
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parametric Mann–Whitney Test. The non-parametric
test also accommodated the presence of the 29 data hav-
ing unknown fecal calprotectin values > 600 μg/g. In
cases where the rankings of the unknown data affected
the P-values of tests, hypothetical FC values that pro-
duced the extreme ranking possibilities were used and
the resulting P-value closest to the significance level was
reported. The test of association (contingency) between
FC ranges and location was performed with the Fisher
Exact Test. Tests were two-sided with a significance
level of 0.05.
Simple linear regression analysis of LAZ (as the re-
sponse variable) and FC was performed on the data from
both groups. Because the rural data included a subset
having FC values > 600 μg/g lacking precise measure-
ment and the absence of these data would bias the re-
gression results, Monte Carlo simulation was used to
account for these data and estimate regression param-
eter values and confidence intervals. The simulated data
were assigned FC values calculated with a function of
the frequency distribution of the measured FC data and
LAZ values were generated with random Gaussian vari-
ation from a line of linear association of LAZ and FC.
The line and the magnitude of the variation were esti-
mated from the frequency distribution and mean of the
LAZ values of the 28 data, the median of the FC
values > 600 μg/g and a slope determined from a series
of preliminary simulations. One thousand sampling
iterations were performed and in each case the 28 gener-
ated values were combined with the 77 accurately mea-
sured data and linear regression performed. Mean slope
and intercept values and their 95% confidence intervals
were calculated from the results.
An estimate of the proportion of the mean negative
LAZ for the rural group that was attributable to gut in-
flammation as indicated by the FC values for that group
was calculated as the difference, expressed as a percent-
age of the mean negative LAZ, between the mean rural
LAZ and the LAZ calculated from the urban (normal








Age, mo 6.0 ± 0.2 6.0 ± 0.2 6.1
Birth wt, kg 3.1 ± 0.4 3.2 ± 0.4 3.0
Weight, kg 7.4 ± 0.9 7.8 ± 0.8 7.0
Length, cm 65.5 ± 2.2 66.1 ± 2.1 64.7
LAZ2 −0.6 ± 0.9 −0.7 ± 0.9 −0.5
WAZ3 −0.3 ± 1.0 −0.1 ± 1.0 −0.5
WLZ4 0.2 ± 1.0 0.4 ± 0.9 −0.1
1Data are presented as mean ± SD; 2Length-for-age Z-score; 3Weight-for-age Z-scoreAnalyses were accomplished using Graphpad Prism (ver-
sion 5.04, GraphPad Software, San Diego CA USA) and
R (version 2.13, The R Project for Statistical Computing,
www.r-project.org).Results
The general characteristics and anthropometric data of
the infants are shown in Table 1. There were 144 infants,
105 from the rural area and 39 from the urban area,
75 M/69 F. The mean age was 6.1 ± 0.2 mo (range: 5 mo
17 d to 6 mo 30 d. The mean values of LAZ, WAZ and
WLZ for the rural infants were significantly lower than
those for the urban infants (P-values < 0.0001, < 0.0001
and 0.0003, respectively). The WLZ scores for males and
females were significantly different for both the urban
and rural infants (P= 0.022 and 0.007, respectively). All
rural infants were breast fed; 20 of the urban infants
were not receiving any breast milk at the time of the
study and 50% received some infant formula. Only a few
Xichou infants received formula. All infants in both
groups received some complementary foods by the age
of four months, including rice, egg yolk and fruit.
The mean values of LAZ, WAZ and WLZ for all sub-
jects with FC values < 350 μg/g, a reported upper cut off
during the first year of life [17], were −0.0007, 0.315 and
0.517 respectively, compared to −0.753, -0.427 and 0.136
for subjects with FC values > 350 μg/g. In each case the
difference was significant (P < 0.0001, < 0.0001 and 0.021
respectively).
The median FC level was 281.5 μg/g (known range:
24.5 ~ 1267.9 μg/g) in all infants. The median FC level
was significantly higher in rural infants (420.9 μg/g,
known range: 24.5-1268 μg/g) than in urban infants
(140.1 μg/g, known range 26.2-1258 μg/g) (P < 0.0001).
The median FC levels were not different for the 75
males (243.8 μg/g, known range: 26.2-1034 μg/g) and 69
females (300.9 μg/g, known range: 24.5-1268 μg/g).
Fifty-six percent and 10% of rural and urban measure-
ments, respectively, were > 350 μg/g. This association of









± 0.2 6.2 ± 0.3 6.3 ± 0.3 6.2 ± 0.2
± 0.4 3.4 ± 0.5 3.5 ± 0.6 3.3 ± 0.4
± 0.8 8.4 ± 0.9 8.9 ± 0.7 7.9 ± 0.8
± 2.1 67.8 ± 2.3 68.6 ± 2.0 67.0 ± 2.3
± 0.9 0.4 ± 0.9 0.4 ± 0.9 0.5 ± 1.0
± 1.0 0.8 ± 0.8 1.0 ± 0.7 0.6 ± 0.8
± 1.0 0.8 ± 0.8 1.1 ± 0.7 0.6 ± 0.7
; 4Weight-for-length Z-score.
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infants showed that the relationship was not significant
(Figure 1, P= 0.34). Addition of an estimate for the sin-
gle datum having an unknown value > 600 μg/g had neg-
ligible effect on these results. Regression analysis of the
rural data using Monte Carlo simulation indicated
that the relationship of LAZ and FC was significant
(P= 0.014); the estimate for the slope was −0.00061 with
a 95% confidence interval of −0.00013 to −0.00109. The
slope confidence interval indicated that LAZ and FC
had a significant inverse relationship; more specifically, a
100 μg/g increase in FC was associated with a 0.06 de-
crease in LAZ. Examination of the residuals indicated no
apparent departures from the regression assumptions.
There was no correlation between birth weight and FC.
The proportion of the low mean LAZ for the rural
group (−0.6) attributable to high FC was estimated to be
31% on average.
Discussion
It should be emphasized that this was an exploratory
study included as a last minute addition to the baseline
data for the parent study in Xichou followed by recogni-
tion of the potential interest in comparing with the
upper-middle income urban children. Sample sizes were
dictated by timelines rather than power testing. Statistics
were complicated by some values for calprotectin in
Xichou infants exceeding expectations and, therefore,
the assay range established for the first batch. Hence,
this should be regarded as a pilot observational study
and our discussion viewed with this in mind.
In our model, the higher median FCC of the rural vs
urban (control) infants accounted for one/third of the
linear growth deficit. The results of this project suggest
that the measurement of calprotectin concentrations inFigure 1 Length-for-age Z-scores as a function of fecal
calprotectin. Symbols denote rural (●) and urban (□) infants.small random fecal samples provides a simple, non-
invasive strategy for the detection of gut inflammation
in apparently normal infants and a measure of the sever-
ity of this inflammation. It has been hypothesized that in
these circumstances there is translocation of immuno-
genic luminal macromolecules across a compromised
gut mucosa leading to stimulation of systemic immuno/
inflammatory processes and subsequent linear growth
impairment [2]. The estimated contribution to linear
growth faltering is less than that estimated for rural
Gambian infants [2]. In contrast, FC levels were not ele-
vated in urban children aged 0–12 y in urban Kampala
[18] which suggests either a more favorable environment
or a protective effect associated with increasing age. The
median FC value of 140 μg/g for the urban infants was a
little higher than that for the only other reported data
for normal infants) at the age of 6 mo [19]. Our urban
data, therefore, provided a quite conservative control for
comparison with the rural infant data. It is noted that
fecal CP levels were subsequently found to be modestly
higher for age in hospitalized young children in Kampala
who were HIV-infected, highly active anti-retroviral-
naïve Ugandan children. Children with advanced disease
had significantly higher FC levels and this also applied to
older children with diarrhea [20].
Consistent with previous studies [19,21-26], the FC
levels observed in healthy 6 mo infants in the current
study were higher than in healthy adults and children.
The high FC levels in infants may reflect the increased
trans-epithelial migration of neutrophil granulocytes
and/or macrophages into the intestinal lumen, which
could be due to the greater intestinal permeability of
young infants and may reflect an increase in leukocyte
migration through the gut mucosa, as part of the devel-
opment of the gut-associated lymphoid tissue which is
particular to this period of life [27].
As ages of urban and rural infants were the same, age-
related differences did not account for the rural versus
urban observed differences in FC. Breast feeding has in
some, but not all, reports have been associated with higher
FC levels in younger infants [24,27]. However, this differ-
ence does not account for the high FC value in the rural
group at 6 months nor for the association between FC and
linear growth in the rural group. Calprotectin levels are
already used and documented extensively in the monitor-
ing of the extent of inflammation of the gut in inflamma-
tory bowel disease [28-30]. However, the application of
this assay in assessing the integrity of the gut mucosa in
infants with growth failure requires further studies pro-
spectively designed to evaluate this as well as other re-
cently proposed inflammatory markers that can be assayed
in the feces. FC has the special advantage in infants and
young children of not requiring venipuncture. The simpli-
city of collection and storage add further advantages.
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These results are consistent with the hypothesis that
chronic sub-clinical intestinal inflammation is a greater
problem in relatively poor rural infants in contrast to
those living in a relatively affluent urban environment.
Moreover, this apparent chronic low-grade inflammation
is associated with impairment of linear growth.
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